Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The Prostate

Showing results (691-700 of 6,084) with videos related to

Pageof 609
Sort By:
The Prostate|August 9, 2020
Abdominal and pelvic adipose tissue distribution and risk of prostate cancer recurrence after radiation therapyClaire M Di Bella, Lauren E Howard, Taofik Oyekunle, et al.
The Prostate|January 1, 1986
Effects of 1.5% glycine infusion on the nonelectrolyte components of serum in dogsP O'Donnell, S A McHan, E P Fody
The Prostate|April 20, 2023
PSA density does not improve predictive accuracy of the UCSF-CAPRA scoreRobert Parker, Alexander Bell, Kevin Chang, et al.
The Prostate|May 16, 2023
Post-diagnostic metformin and statin use and risk of biochemical recurrence in Veterans diagnosed with prostate cancerSaira Khan, Su-Hsin Chang, Amanda A Seyerle, et al.
The Prostate|January 1, 1989
Crystalloids in latent prostatic carcinomaM Furusato, H Kato, H Takahashi, et al.
The Prostate|July 2, 2020
Modulating tumor reactive stroma by extracorporeal shock waves to control prostate cancer progressionLetizia Rinella, Benedetta Pizzo, Roberto Frairia, et al.
The Prostate|July 7, 2020
Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancerSarah Bonk, Martina Kluth, Kristina Jansen, et al.
The Prostate|July 7, 2020
miR-196a-mediated downregulation of p27<sup>kip1</sup> protein promotes prostate cancer proliferation and relates to biochemical recurrence after radical prostatectomyBin Zhan, Linjin Huang, Yachun Chen, et al.
The Prostate|July 14, 2020
Prostate cancer-specific mortality burden by risk group among men with localized disease: Implications for research and clinical trial prioritiesEdward Christopher Dee, Michelle D Nezolosky, Fallon E Chipidza, et al.
The Prostate|July 21, 2020
Identifying and treating ROBO1<sup>-ve</sup> /DOCK1<sup>+ve</sup> prostate cancer: An aggressive cancer subtype prevalent in African American patientsMarina G Ferrari, Arsheed A Ganaie, Ashraf Shabenah, et al.
Pageof 609

Showing results (691-700 of 6,084) with videos related to

Sort By:
Pageof 609
The Prostate|August 9, 2020
Abdominal and pelvic adipose tissue distribution and risk of prostate cancer recurrence after radiation therapyClaire M Di Bella, Lauren E Howard, Taofik Oyekunle, et al.
The Prostate|January 1, 1986
Effects of 1.5% glycine infusion on the nonelectrolyte components of serum in dogsP O'Donnell, S A McHan, E P Fody
The Prostate|April 20, 2023
PSA density does not improve predictive accuracy of the UCSF-CAPRA scoreRobert Parker, Alexander Bell, Kevin Chang, et al.
The Prostate|May 16, 2023
Post-diagnostic metformin and statin use and risk of biochemical recurrence in Veterans diagnosed with prostate cancerSaira Khan, Su-Hsin Chang, Amanda A Seyerle, et al.
The Prostate|January 1, 1989
Crystalloids in latent prostatic carcinomaM Furusato, H Kato, H Takahashi, et al.
The Prostate|July 2, 2020
Modulating tumor reactive stroma by extracorporeal shock waves to control prostate cancer progressionLetizia Rinella, Benedetta Pizzo, Roberto Frairia, et al.
The Prostate|July 7, 2020
Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancerSarah Bonk, Martina Kluth, Kristina Jansen, et al.
The Prostate|July 7, 2020
miR-196a-mediated downregulation of p27<sup>kip1</sup> protein promotes prostate cancer proliferation and relates to biochemical recurrence after radical prostatectomyBin Zhan, Linjin Huang, Yachun Chen, et al.
The Prostate|July 14, 2020
Prostate cancer-specific mortality burden by risk group among men with localized disease: Implications for research and clinical trial prioritiesEdward Christopher Dee, Michelle D Nezolosky, Fallon E Chipidza, et al.
The Prostate|July 21, 2020
Identifying and treating ROBO1<sup>-ve</sup> /DOCK1<sup>+ve</sup> prostate cancer: An aggressive cancer subtype prevalent in African American patientsMarina G Ferrari, Arsheed A Ganaie, Ashraf Shabenah, et al.
Pageof 609